Pharsight

MODERNA PATENTS FACING OPPOSITIONS

Top patents of MODERNA facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3590949B1 18 May, 2022 Ribonucleic acids containing n1-methyl-pseudouracils and uses thereof Oct, 2031 10
EP2791160B1 02 Mar, 2022 Modified mrna compositions Dec, 2032 10
EP3682905B1 01 Dec, 2021 Modified nucleosides, nucleotides, and nucleic acids, and uses thereof Oct, 2032 10
EP3134131B1 22 Dec, 2021 Nucleic acid vaccines Apr, 2035 5
EP3718565B1 27 Apr, 2022 Respiratory virus vaccines Oct, 2036 4
EP3625345B1 24 May, 2023 Modified messenger rna comprising functional rna elements NA 2
EP3458083B1 02 Nov, 2022 Polynucleotides encoding interleukin-12 (il12) and uses thereof May, 2037 2
EP3019619B1 25 Aug, 2021 Compositions comprising synthetic polynucleotides encoding crispr related proteins and synthetic sgrnas and methods of use Jul, 2034 2
EP3431485B1 30 Dec, 2020 Engineered nucleic acids and methods of use thereof Oct, 2031 2
EP3492109B1 04 Mar, 2020 Modified nucleosides, nucleotides, and nucleic acids, and uses thereof Oct, 2032 2
EP3359670B2 14 Feb, 2024 Methods for therapeutic administration of messenger ribonucleic acid drugs Oct, 2036 1
EP3324979B1 12 Oct, 2022 Infectious disease vaccines Jul, 2036 1
EP2922554B1 23 Feb, 2022 Terminally modified rna Oct, 2033 1
EP3394030B1 22 Dec, 2021 Compounds and compositions for intracellular delivery of agents Dec, 2036 1
EP3350333B1 27 Oct, 2021 Polynucleotides containing a stabilizing tail region Sep, 2036 1